Medtronic plc. Ordinary Shares
MDT · NYSE
Analyst Consensus
Buy
Analyst Ratings Synthesis
The consensus is Buy across 27 analysts, with a reported mean price target of $96. Targets do not cluster in any verifiable range because the supplied consensus lists both the low and high as unavailable, so the width of the target spread cannot be calculated. No named analyst or firm is identified as most bullish or least bullish. The evidence also shows no rating or target revisions during the past week. Consequently, the substantive disagreement behind the apparent gap between the mean target and the $86.20 close is not documented: there is no analyst-level commentary explaining valuation, growth, execution, or risk, and no basis for comparing individual views.
Rating Actions
No individual rating actions have been captured for MDTyet. Consensus figures above come from Nasdaq's aggregate feed.
